STOCK TITAN

Emeren (SOL) Gets $2.00/ADS Cash Offer with Shah Capital Support

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Shah Capital Management, Shah Capital Opportunity Fund LP and their President/CIO, Himanshu H. Shah (collectively the “Reporting Persons”) have filed Amendment No. 9 to their Schedule 13D on Emeren Group Ltd (NYSE: SOL). The amendment is triggered by the execution, on 18 June 2025, of an Agreement and Plan of Merger between Emeren, Shurya Vitra Ltd. ("Parent") and Emeren Holdings Ltd. ("Merger Sub").

Key ownership data: the Reporting Persons beneficially own 18,818,236 American Depositary Shares (ADSs), equal to 36.67 % of Emeren’s outstanding Ordinary Shares (each ADS represents ten Ordinary Shares). Voting and dispositive power is shared over 18,761,866 ADSs; Mr. Shah holds sole power over 56,370 ADSs.

Merger economics: • Each Ordinary Share will be converted into the right to receive US$0.20 in cash. • Each ADS will receive US$2.00 in cash. Excluded Shares, treasury shares and shares owned by Parent will be cancelled without consideration. Dissenting shareholders may pursue fair-value appraisal rights under Section 179 of the BVI Business Companies Act.

Equity awards: Vested options and RSUs will be cashed out based on the per-share consideration; unvested awards will roll into substantially similar awards of the surviving entity.

Process & governance: The Merger was unanimously approved by Emeren’s Board following a unanimous recommendation of a three-member independent special committee. The Company is subject to customary no-shop and fiduciary-out provisions. Closing is conditioned on shareholder approval, regulatory clearances and absence of injunctions. The outside date is 31 December 2025.

Financing & guarantees: Mr. Shah signed an Equity Commitment Letter to provide capital sufficient to fund the cash consideration and related costs. He also delivered a Limited Guarantee covering the US$4.5 million reverse termination fee payable by Parent under specified circumstances. Reciprocal US$4.5 million termination fees apply to both parties.

Support agreements: Certain existing shareholders ("Rollover Securityholders") have signed a Rollover and Support Agreement to vote their securities in favour of the Merger and to cancel their shares at closing.

Post-closing: Upon completion, Emeren will become a wholly owned subsidiary of Parent, its Ordinary Shares and ADSs will be delisted from the NYSE and deregistered under the Exchange Act.

Material take-aways for investors: 1) A cash exit at US$2.00/ADS is now on the table and backed by holders of more than one-third of the equity. 2) Minority shareholders must evaluate the adequacy of the offer ahead of a forthcoming vote and consider appraisal options. 3) Transaction is expected to close by 31 Dec 2025, subject to customary conditions.

Positive

  • Cash consideration of US$2.00 per ADS provides a clear liquidity event for shareholders.
  • 36.67 % ownership stake by the Reporting Persons aligns significant voting power behind the transaction, increasing likelihood of completion.
  • Board and special committee unanimously approved the Merger Agreement, indicating robust corporate-governance process.
  • Equity commitment and guarantee from Himanshu H. Shah mitigate financing risk.

Negative

  • Shares will be delisted and deregistered, removing public-market liquidity for those who retain ownership post-closing.
  • Offer price caps upside; investors believing intrinsic value exceeds US$2.00/ADS may view the deal as undervalued.
  • Long stop date of 31 Dec 2025 introduces a potential six-month+ wait, creating time-value drag.

Insights

TL;DR 36.7 % holder backs US$2.00/ADS cash buyout; board and special committee are on board; deal hinges on minority vote.

The filing solidifies the buy-out structure announced 18 June 2025. A cash merger at US$2.00 per ADS represents full liquidity for public investors and is fully financed via Mr. Shah’s equity commitment, limiting financing risk. Board and special-committee unanimity strengthens the transaction’s defensibility against litigation. With a 36 % voting bloc already supportive and rollover shareholders committed, the hurdle for shareholder approval is lowered, though a simple majority of votes cast (per BVI law and company articles) is still required. Termination fees of US$4.5 million on both sides align incentives but are relatively small, implying limited break-fee deterrence. Key timing risk is the 31 Dec 2025 outside date.

TL;DR Cash exit set; delisting risk if deal proceeds; upside now capped at US$2.00/ADS.

From a portfolio perspective the filing crystallises the investment thesis around a near-term event. The 36 % stake and support agreement make completion probable. For existing holders, upside is now limited to the US$2.00 offer minus time value and deal risk. Downside hinges on stand-alone fundamentals, which are not addressed in this filing. Liquidity will disappear post-closing, so investors needing public markets access should plan exits beforehand. The dissenter right under BVI law offers a path for those viewing the consideration as inadequate, but entails legal cost and timing uncertainty.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
The share value represents the number of American Depositary Shares beneficially owned by the Reporting Person. Each American Depositary Share represents ten Ordinary Shares. Percentage is based on 513,216,222 Ordinary Shares outstanding as of March 31, 2025, as provided in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on May 14, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
The share value represents the number of American Depositary Shares beneficially owned by the Reporting Person. Each American Depositary Share represents ten Ordinary Shares. Percentage is based on 513,216,222 Ordinary Shares outstanding as of March 31, 2025, as provided in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on May 14, 2025.


SCHEDULE 13D




Comment for Type of Reporting Person:
The share value represents the number of American Depositary Shares beneficially owned by the Reporting Person. Each American Depositary Share represents ten Ordinary Shares. Percentage is based on 513,216,222 Ordinary Shares outstanding as of March 31, 2025, as provided in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on May 14, 2025.


SCHEDULE 13D


Shah Capital Management
Signature:/s/ Himanshu H. Shah
Name/Title:Himanshu H. Shah, President and Chief Investment Officer
Date:06/20/2025
Shah Capital Opportunity Fund LP
Signature:/s/ Himanshu H. Shah
Name/Title:Himanshu H. Shah, Managing Member
Date:06/20/2025
Himanshu H. Shah
Signature:/s/ Himanshu H. Shah
Name/Title:Himanshu H. Shah
Date:06/20/2025

FAQ

What price will Emeren (SOL) shareholders receive in the merger?

Each Ordinary Share will receive US$0.20 and each ADS will receive US$2.00 in cash.

How much of Emeren does Shah Capital currently own?

The Reporting Persons beneficially own 18,818,236 ADSs, representing 36.67 % of outstanding Ordinary Shares.

When is the merger expected to close?

The Merger Agreement sets an outside date of 31 December 2025, subject to customary conditions and shareholder approval.

Will Emeren remain listed after the transaction?

No. Upon completion, Emeren’s Ordinary Shares and ADSs will be delisted from the NYSE and deregistered under the Exchange Act.

What happens to existing stock options and RSUs?

Vested awards are cashed out at the merger price; unvested awards roll into similar incentives of the surviving entity.

Do minority shareholders have appraisal rights?

Yes. Dissenting holders may seek fair value under Section 179 of the BVI Business Companies Act.
Emeren Group

NYSE:SOL

SOL Rankings

SOL Latest News

SOL Latest SEC Filings

SOL Stock Data

99.56M
50.78M
1.06%
42.57%
1.68%
Solar
Electric & Other Services Combined
Link
United States
NORWALK